metoclopramide has been researched along with dacarbazine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M | 1 |
| Ballatori, E; Basurto, C; Buzzi, F; Calabresi, F; Del Favero, A; Roila, F; Tonato, M | 1 |
| Ballerini, P; Bonmassar, E; Franchi, A; Fuschiotti, P; Piccioni, D | 1 |
| Agostinucci, WA; Gannon, RH; Schauer, PK; Walters, JK | 1 |
| Czarnetzki, BM; Kolde, G | 1 |
| Bolton, JA; Bowcock, SJ; Kang, AA; Retsas, S; Stockdale, AD | 1 |
| Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U | 1 |
| Clark, RA; Gralla, RJ; Tyson, LB | 1 |
1 review(s) available for metoclopramide and dacarbazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for metoclopramide and dacarbazine
| Article | Year |
|---|---|
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Melanoma; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Sarcoma; Vomiting | 1992 |
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
Topics: Dacarbazine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Prospective Studies; Random Allocation; Vomiting | 1989 |
[High-dosage metoclopramide versus lorazepam in cytostatic-induced gastrointestinal side effects].
Topics: Anti-Anxiety Agents; Dacarbazine; Gastrointestinal Diseases; Humans; Lorazepam; Metoclopramide | 1983 |
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1984 |
8 other study(ies) available for metoclopramide and dacarbazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.
Topics: Animals; Antiemetics; Dacarbazine; Dexamethasone; Diazepam; Drug Therapy, Combination; Leukemia L1210; Male; Metoclopramide; Mice; Neoplasm Transplantation; Orphenadrine | 1989 |
Continuous infusion of metoclopramide for prevention of chemotherapy-induced emesis.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Dacarbazine; Female; Humans; Infusions, Parenteral; Male; Metoclopramide; Middle Aged; Vomiting | 1986 |
[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
Topics: Budd-Chiari Syndrome; Dacarbazine; Humans; Male; Melanoma; Metoclopramide; Middle Aged; Mycobacterium bovis; Skin Neoplasms; Vomiting | 1980 |
High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.
Topics: Adult; Aged; Dacarbazine; Humans; Metoclopramide; Middle Aged; Vomiting | 1982 |